Return to Search
EN
The risk factors for Acute Myeloid Leukemia (AML) are as follows:
1. Radiation Exposure: Exposure to high doses of ionizing radiation (e.g., previous radiotherapy or working in areas with high radiation such as nuclear power plants) can increase the risk.
2. Chemical Exposure: Exposure to certain chemicals like benzene increases the risk of AML. Smoking is a significant risk factor due to its benzene content.
3. Congenital Genetic Disorders: Certain inherited DNA disorders, such as Down Syndrome and Fanconi Anemia, can increase the risk of AML development.
4. Pre-existing Blood Disorders: Hematological conditions such as Myelodysplastic Syndrome (MDS), Essential Thrombocytosis, Polycythemia Vera, or Myelofibrosis have the potential to transform into AML.
5. Previous Cancer Treatments: Patients with a history of chemotherapy, particularly those involving alkylating agents or topoisomerase inhibitors, and radiotherapy, have an increased risk of secondary AML.
6. Family History and Genetics: While most AML cases are not hereditary, a family history of hematological cancers can slightly increase the risk. Some rare genetic syndromes also raise the risk.
7. Gender: AML incidence is slightly higher in men than in women.
8. Age: While AML can occur at any age, its incidence increases with age and is generally more common in older individuals.
What are the risks of Acute Myeloid Leukemia (AML)?
1. Radiation Exposure: Exposure to high doses of ionizing radiation (e.g., previous radiotherapy or working in areas with high radiation such as nuclear power plants) can increase the risk.
2. Chemical Exposure: Exposure to certain chemicals like benzene increases the risk of AML. Smoking is a significant risk factor due to its benzene content.
3. Congenital Genetic Disorders: Certain inherited DNA disorders, such as Down Syndrome and Fanconi Anemia, can increase the risk of AML development.
4. Pre-existing Blood Disorders: Hematological conditions such as Myelodysplastic Syndrome (MDS), Essential Thrombocytosis, Polycythemia Vera, or Myelofibrosis have the potential to transform into AML.
5. Previous Cancer Treatments: Patients with a history of chemotherapy, particularly those involving alkylating agents or topoisomerase inhibitors, and radiotherapy, have an increased risk of secondary AML.
6. Family History and Genetics: While most AML cases are not hereditary, a family history of hematological cancers can slightly increase the risk. Some rare genetic syndromes also raise the risk.
7. Gender: AML incidence is slightly higher in men than in women.
8. Age: While AML can occur at any age, its incidence increases with age and is generally more common in older individuals.